Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT04080076
What this trial is testing

Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

Who this might be right for
Renal Disease
NephroNet, Inc.
Early research (Phase 1)Not Yet RecruitingNCT07783815
What this trial is testing

Evaluate the Efficacy and Safety of Intravesical Instillation of Disitamab Vedotin Combined With Toripalimab in Patients With HER2-Positive High-Risk Non-Muscle Invasive Bladder Cancer Who Are BCG-Naïve or Have BCG Failure

Who this might be right for
Bladder Cancer
Xiangya Hospital of Central South University 20
Not applicableStudy completedNCT02148991
What this trial is testing

Clinical Trial in Patients With Hypertension and Left Ventricular Dysfunction

Who this might be right for
HypertensionCardiac ArrhythmiasDiabetes Mellitus+2 more
Elpen Pharmaceutical Co. Inc. 100
Large-scale testing (Phase 3)Study completedNCT00053820
What this trial is testing

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical Research Council 670
Post-approval studies (Phase 4)Study completedNCT06641440
What this trial is testing

Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test

Who this might be right for
Recurrent Pregnancy Loss, Not PregnantRecurrent Implantation Failure
Centre for Endocrinology and Reproductive Medicine, Italy 42
Testing effectiveness (Phase 2)WithdrawnNCT07090174
What this trial is testing

CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Who this might be right for
HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal Cancer+2 more
University of California, San Diego
Testing effectiveness (Phase 2)Looking for participantsNCT05113368
What this trial is testing

Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer

Who this might be right for
Ovarian CancerSerous Ovarian Cancer
Sarah K. Lynam MD 31
Early research (Phase 1)Study completedNCT06894771
What this trial is testing

MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5
Early research (Phase 1)Looking for participantsNCT07228364
What this trial is testing

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT01136733
What this trial is testing

E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior Vascular Endothelial Growth Factor (VEGF)-Targeted Treatment

Who this might be right for
Metastatic Renal Cell Carcinoma
Eisai Inc. 173
Testing effectiveness (Phase 2)WithdrawnNCT05033132
What this trial is testing

A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Agenus Inc.
Early research (Phase 1)UnknownNCT05990621
What this trial is testing

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

Who this might be right for
CD70-positive Advanced Urologic Neoplasms
Changhai Hospital 60
Early research (Phase 1)Study completedNCT03873038
What this trial is testing

Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

Who this might be right for
Renal DialysisKidney Failure, Chronic
Merck Sharp & Dohme LLC 38
Testing effectiveness (Phase 2)Study completedNCT02079896
What this trial is testing

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Who this might be right for
AnemiaEnd Stage Renal Disease
TME Pharma AG 33
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Testing effectiveness (Phase 2)Ended earlyNCT02401542
What this trial is testing

Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Urothelial Cell CarcinomaUrinary Bladder DiseaseUrological Diseases
Rainier Therapeutics 71
Post-approval studies (Phase 4)UnknownNCT03502031
What this trial is testing

Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Who this might be right for
Renal Insufficiency, ChronicDiabetic Nephropathy Type 2
James A. Tumlin, MD 72
Early research (Phase 1)Study completedNCT02367872
What this trial is testing

Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment

Who this might be right for
Renal ImpairmentHepatic Impairment
Takeda 48
Not applicableStudy completedNCT02576873
What this trial is testing

Long-term Outcome of End-stage Renal Disease Patients Treated With Hig-efficiency Hemodiafiltration

Who this might be right for
End-stage Renal Disease
Chulalongkorn University 66
Testing effectiveness (Phase 2)Study completedNCT00019396
What this trial is testing

Flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Who this might be right for
Stage IV MelanomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer+1 more
National Cancer Institute (NCI)
Next Page